West Orange, NJ, United States of America

Elijah H Gold

This inventor holds 42 USPTO granted patents, plus 1 CIPO patent, primarily in Pharmaceutical Compositions. Top assignee: Schering Corporation. Active years: 1976-1994.


% Patents Active = 100.0


Average Co-Inventor Count = 2.1

ph-index = 11

Forward Citations = 370(Granted Patents)


Company Filing History:


Years Active: 1976-1994

Loading Chart...
Loading Chart...
Areas of Expertise:
Antihypertensive Agents
Antiglaucoma Compositions
Carboxyalkyl Dipeptides
Fused Benzazepines
Angiotensin-Converting Enzyme Inhibitors
Pharmaceutical Compositions
Antiulcer Compounds
Dermatological Methods
Novel Benzimidazoles
Poultry Coccidiosis Treatments
Tricyclic Imidazo Compounds
42 patents (USPTO):Explore Patents

Title: Innovations of Elijah H. Gold: A Pioneering Inventor in Pharmacology

Introduction: Elijah H. Gold, based in West Orange, NJ, has made significant contributions to the field of pharmacology with an impressive portfolio of 42 patents. His innovative work focuses on developing compounds that have therapeutic applications, particularly in addressing pressing health issues such as hypertension and mental health disorders.

Latest Patents: Two of his latest patents demonstrate his dedication to advancing medical science. The first patent details "Carboxyalkyl dipeptides," which are described as compounds with the potential to serve as antihypertensive agents. The second patent involves "Fused benzazepines," which encompass a class of compounds that hold promise for the treatment of psychoses and depression, along with methods of utilizing these compounds and their pharmaceutical compositions.

Career Highlights: Elijah H. Gold has established himself as a leading inventor in his domain, particularly through his tenure at Schering Corporation. His contributions have not only led to numerous patents but also have sparked advancements in drug development, enhancing treatment methodologies across various health conditions.

Collaborations: Throughout his career, Elijah has collaborated with notable colleagues such as Bernard R. Neustadt and Wei K. Chang. These partnerships have helped foster innovation and push the boundaries of medical research, underscoring the importance of teamwork in the path to discovery.

Conclusion: Elijah H. Gold's work is a testament to the impact that dedicated inventors can have on healthcare. With a robust portfolio of patents and collaborative efforts, he continues to inspire future innovations in the pharmaceutical industry. His commitment to improving health outcomes through his inventions remains a significant part of his legacy.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…